A Randomised Phase II Clinical Trial of Low-Dose Cyclophosphamide and Transarterial Chemoembolization (TACE) with or Without Vaccination with Dendritic Cells (DC) Pulsed with HepG2 Lysate Ex Vivo in Patients with Hepatocellular Carcinoma (HCC): the ImmunoTACE Trial.
JOURNAL OF CLINICAL ONCOLOGY(2022)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要